Sitagliptin attenuated the progress of atherosclerosis in ApoE knockout mice via AMP-activated protein kinase (AMPK) and Mitogen-activated protein kinase (MAPK)-dependent mechanisms followed by reducing leukocyte-endothelial cell interaction and inflammation reactions. This evidence concerns the gene APOE and atherosclerosis.